Expression of redox pathway enzymes in human prostatic tissue

Alexander Valdman, Lars Häggarth, Liang Cheng, Antonio Lopez-Beltran, Rodolfo Montironi, Peter Ekman, Lars Egevad

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

OBJECTIVE: To evaluate the involvement of thioredoxin reductase (TxnR), thioredoxin (Trx) and peroxiredoxins (Prdx) in prostate cancer (PCa) and to assess the potential prognostic importance of these redox-regulated pathways. STUDY DESIGN: Expression of the isoforms TxnR2, Trx1 and Prdx2 was studied by immunohistochemistry on tissue microarrays (TMAs). In a prognostic TMA, 294 primary cases of PCa with a median follow-up of 49 months were stained for Trx1 and Prdx2. Another TMA containing benign prostatic tissue, atrophy, high grade prostatic intraepithelial neoplasia (HGPIN) and PCa from 40 patients was stained with all 3 antibodies. RESULTS: All 3 proteins showed similar expression patterns, with the highest immunoreactivity in HGPIN followed by atrophy, PCa and benign tissue. TxnR2, Trx1 and Prdx2 were overexpressed in HGPIN and PCa compared with benign tissue (p < 0.001), and Trx1 and Prdx2 were also overexpressed in HGPIN compared with PCa (p<0.001). Trx1 and Prdx2 did not correlate with biochemical recurrence. CONCLUSION: This study demonstrates up-regulation of the redox pathway proteins in PCa and its precursor lesions. The pathogenetic role of the redox system remains to be investigated.

Original languageEnglish
Pages (from-to)367-374
Number of pages8
JournalAnalytical and Quantitative Cytology and Histology
Volume31
Issue number6
StatePublished - Dec 2009

Fingerprint

Oxidation-Reduction
Prostatic Neoplasms
Prostatic Intraepithelial Neoplasia
Enzymes
Atrophy
Thioredoxin-Disulfide Reductase
Peroxiredoxins
Thioredoxins
Protein Isoforms
Proteins
Up-Regulation
Immunohistochemistry
Recurrence
Antibodies

Keywords

  • Cancer, prostate
  • Immunohistochemistry
  • Neoplasia, prostatic intraepithelial
  • Peroxiredoxin
  • Thioredoxin
  • Thioredoxin reductase
  • Tissue microarray

ASJC Scopus subject areas

  • Anatomy
  • Histology

Cite this

Valdman, A., Häggarth, L., Cheng, L., Lopez-Beltran, A., Montironi, R., Ekman, P., & Egevad, L. (2009). Expression of redox pathway enzymes in human prostatic tissue. Analytical and Quantitative Cytology and Histology, 31(6), 367-374.

Expression of redox pathway enzymes in human prostatic tissue. / Valdman, Alexander; Häggarth, Lars; Cheng, Liang; Lopez-Beltran, Antonio; Montironi, Rodolfo; Ekman, Peter; Egevad, Lars.

In: Analytical and Quantitative Cytology and Histology, Vol. 31, No. 6, 12.2009, p. 367-374.

Research output: Contribution to journalArticle

Valdman, A, Häggarth, L, Cheng, L, Lopez-Beltran, A, Montironi, R, Ekman, P & Egevad, L 2009, 'Expression of redox pathway enzymes in human prostatic tissue', Analytical and Quantitative Cytology and Histology, vol. 31, no. 6, pp. 367-374.
Valdman A, Häggarth L, Cheng L, Lopez-Beltran A, Montironi R, Ekman P et al. Expression of redox pathway enzymes in human prostatic tissue. Analytical and Quantitative Cytology and Histology. 2009 Dec;31(6):367-374.
Valdman, Alexander ; Häggarth, Lars ; Cheng, Liang ; Lopez-Beltran, Antonio ; Montironi, Rodolfo ; Ekman, Peter ; Egevad, Lars. / Expression of redox pathway enzymes in human prostatic tissue. In: Analytical and Quantitative Cytology and Histology. 2009 ; Vol. 31, No. 6. pp. 367-374.
@article{327734f6abed4daa86f1b5d47f77e6ef,
title = "Expression of redox pathway enzymes in human prostatic tissue",
abstract = "OBJECTIVE: To evaluate the involvement of thioredoxin reductase (TxnR), thioredoxin (Trx) and peroxiredoxins (Prdx) in prostate cancer (PCa) and to assess the potential prognostic importance of these redox-regulated pathways. STUDY DESIGN: Expression of the isoforms TxnR2, Trx1 and Prdx2 was studied by immunohistochemistry on tissue microarrays (TMAs). In a prognostic TMA, 294 primary cases of PCa with a median follow-up of 49 months were stained for Trx1 and Prdx2. Another TMA containing benign prostatic tissue, atrophy, high grade prostatic intraepithelial neoplasia (HGPIN) and PCa from 40 patients was stained with all 3 antibodies. RESULTS: All 3 proteins showed similar expression patterns, with the highest immunoreactivity in HGPIN followed by atrophy, PCa and benign tissue. TxnR2, Trx1 and Prdx2 were overexpressed in HGPIN and PCa compared with benign tissue (p < 0.001), and Trx1 and Prdx2 were also overexpressed in HGPIN compared with PCa (p<0.001). Trx1 and Prdx2 did not correlate with biochemical recurrence. CONCLUSION: This study demonstrates up-regulation of the redox pathway proteins in PCa and its precursor lesions. The pathogenetic role of the redox system remains to be investigated.",
keywords = "Cancer, prostate, Immunohistochemistry, Neoplasia, prostatic intraepithelial, Peroxiredoxin, Thioredoxin, Thioredoxin reductase, Tissue microarray",
author = "Alexander Valdman and Lars H{\"a}ggarth and Liang Cheng and Antonio Lopez-Beltran and Rodolfo Montironi and Peter Ekman and Lars Egevad",
year = "2009",
month = "12",
language = "English",
volume = "31",
pages = "367--374",
journal = "Analytical and Quantitative Cytopathology and Histopathology",
issn = "0301-102X",
publisher = "John Rylands University Library",
number = "6",

}

TY - JOUR

T1 - Expression of redox pathway enzymes in human prostatic tissue

AU - Valdman, Alexander

AU - Häggarth, Lars

AU - Cheng, Liang

AU - Lopez-Beltran, Antonio

AU - Montironi, Rodolfo

AU - Ekman, Peter

AU - Egevad, Lars

PY - 2009/12

Y1 - 2009/12

N2 - OBJECTIVE: To evaluate the involvement of thioredoxin reductase (TxnR), thioredoxin (Trx) and peroxiredoxins (Prdx) in prostate cancer (PCa) and to assess the potential prognostic importance of these redox-regulated pathways. STUDY DESIGN: Expression of the isoforms TxnR2, Trx1 and Prdx2 was studied by immunohistochemistry on tissue microarrays (TMAs). In a prognostic TMA, 294 primary cases of PCa with a median follow-up of 49 months were stained for Trx1 and Prdx2. Another TMA containing benign prostatic tissue, atrophy, high grade prostatic intraepithelial neoplasia (HGPIN) and PCa from 40 patients was stained with all 3 antibodies. RESULTS: All 3 proteins showed similar expression patterns, with the highest immunoreactivity in HGPIN followed by atrophy, PCa and benign tissue. TxnR2, Trx1 and Prdx2 were overexpressed in HGPIN and PCa compared with benign tissue (p < 0.001), and Trx1 and Prdx2 were also overexpressed in HGPIN compared with PCa (p<0.001). Trx1 and Prdx2 did not correlate with biochemical recurrence. CONCLUSION: This study demonstrates up-regulation of the redox pathway proteins in PCa and its precursor lesions. The pathogenetic role of the redox system remains to be investigated.

AB - OBJECTIVE: To evaluate the involvement of thioredoxin reductase (TxnR), thioredoxin (Trx) and peroxiredoxins (Prdx) in prostate cancer (PCa) and to assess the potential prognostic importance of these redox-regulated pathways. STUDY DESIGN: Expression of the isoforms TxnR2, Trx1 and Prdx2 was studied by immunohistochemistry on tissue microarrays (TMAs). In a prognostic TMA, 294 primary cases of PCa with a median follow-up of 49 months were stained for Trx1 and Prdx2. Another TMA containing benign prostatic tissue, atrophy, high grade prostatic intraepithelial neoplasia (HGPIN) and PCa from 40 patients was stained with all 3 antibodies. RESULTS: All 3 proteins showed similar expression patterns, with the highest immunoreactivity in HGPIN followed by atrophy, PCa and benign tissue. TxnR2, Trx1 and Prdx2 were overexpressed in HGPIN and PCa compared with benign tissue (p < 0.001), and Trx1 and Prdx2 were also overexpressed in HGPIN compared with PCa (p<0.001). Trx1 and Prdx2 did not correlate with biochemical recurrence. CONCLUSION: This study demonstrates up-regulation of the redox pathway proteins in PCa and its precursor lesions. The pathogenetic role of the redox system remains to be investigated.

KW - Cancer, prostate

KW - Immunohistochemistry

KW - Neoplasia, prostatic intraepithelial

KW - Peroxiredoxin

KW - Thioredoxin

KW - Thioredoxin reductase

KW - Tissue microarray

UR - http://www.scopus.com/inward/record.url?scp=74549225085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74549225085&partnerID=8YFLogxK

M3 - Article

C2 - 20698352

AN - SCOPUS:74549225085

VL - 31

SP - 367

EP - 374

JO - Analytical and Quantitative Cytopathology and Histopathology

JF - Analytical and Quantitative Cytopathology and Histopathology

SN - 0301-102X

IS - 6

ER -